June Lunch: Why Your Startup Needs a Chief of Staff

Does your startup need a chief of staff (CoS)? At our June lunch, Cheston Newhall, the recently appointed chief of staff for Bamboo Health, shared why the role is important in startups, how it can take on different forms, and how a CoS can be a strategic growth lever, if used correctly. He noted that […]

Photo by Austin Lopesilvero

Does your startup need a chief of staff (CoS)? At our June lunch, Cheston Newhall, the recently appointed chief of staff for Bamboo Health, shared why the role is important in startups, how it can take on different forms, and how a CoS can be a strategic growth lever, if used correctly. He noted that many CoS roles are popping up in tech companies, but cautioned against hiring one simply because it’s the trendy thing to do. Read more in this KY INNO article.

Newhall joined Bamboo Health, a national collaborative care network, in 2022. As CoS, he leads special initiatives and projects for the CEO and partners with company leaders to drive the business’ priorities through strategy, development and operations. He also maintains and builds relationships with Bamboo Health’s board of directors, as well as current and future investors, partners and collaborators.

Newhall has a wealth of experience in fast-growing technology companies, with expertise in organizational growth, business development and go-to-market strategies. He previously served as a sales alliance leader for Bamboo Health’s holding company, Appriss, playing a role in the successful acquisition of its Appriss Insights business unit by Equifax in 2021 for $1.8 billion. Prior to Appriss, Newhall held sales and revenue management positions at TEKSystems and ZirMed (Waystar).

February Lunch: Apellis Success Story

At our February lunch, President and CEO Cedric Francois, MD, PhD, shared the inspiring success story of Crestwood, Ky.-based Apellis Pharmaceuticals Inc. He talked about his experiences with taking the pharmaceutical company public, as well as finding/attracting talent and securing funding. Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds […]

At our February lunch, President and CEO Cedric Francois, MD, PhD, shared the inspiring success story of Crestwood, Ky.-based Apellis Pharmaceuticals Inc. He talked about his experiences with taking the pharmaceutical company public, as well as finding/attracting talent and securing funding.

Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases. Dr. Francois co-founded the company in September 2009, and it now has clinical and manufacturing operations all over the world. He also co-founded Potentia Pharmaceuticals Inc., a private biotechnology company that operates as a subsidiary of Apellis, and has served as its President and CEO since 2001.

Dr. Francois earned his medical degree from the University of Leuven in Belgium and his PhD in physiology from the University of Louisville. Following postgraduate training in pediatric and transplant surgery, Dr. Francois served on the research team that performed the first successful hand transplant, of the Louisville Face Transplant Team, whose work supported hand transplantation in Lyon, France in 2005.